For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Prucalopride | A single dose of 2mg prucalopride, administered orally as tablets with 125mL of water on Day 1. | None | None | 0 | 13 | 3 | 13 | View |
| Polyethylene Glycol | 13.8g polyethylene glycol (PEG) 3350 with sodium bicarbonate, sodium chloride, and potassium chloride as a solution in water. Administered twice orally on Day 1 (once in the morning and once prior to lunch). | None | None | 0 | 12 | 0 | 12 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| ABDOMINAL PAIN | None | Gastrointestinal disorders | None | View |
| DIARRHOEA | None | Gastrointestinal disorders | None | View |
| NAUSEA | None | Gastrointestinal disorders | None | View |
| RECTAL HAEMORRHAGE | None | Gastrointestinal disorders | None | View |
| HEADACHE | None | Nervous system disorders | None | View |